BioMedSA’s Board of Directors approved 2 new memberships in May 2023: iGenomeDX and Aiculus.
iGenomeDx is a San Antonio based molecular diagnostic laboratory whose mission is to enhance decision-making for physicians, increase the quality of care for patients, and lower the costs of healthcare for everyone by providing reliable genetic testing services. Testing services in their CLIA- certified laboratory include pharmacogenomics, infectious disease, and toxicology. Precision diagnostics provides personalized care and a more direct pathway of treatment thereby increasing positive outcomes and decreasing the impact of side-effects. With a research-driven team comprising scientists with specialties inluding: microbiology, neuroimmunology, infectious disease, genomics, bioinformatics, cell & molecular biology, biochemistry, pharmD, and chemical engineering, iGenomeDx seeks to integrate cutting-edge science, patient care and customer service at the center of their work.
Aiculus is a cybersecurity company that provides a proprietary AI-powered cybersecurity products and advisory services. The Aiculus flagship product is used by organizations to detect and respond to API security threats in real-time. Prioritizing data privacy and API threat intelligence sharing, Aiculus seeks to prevent breaches on operational API systems supporting an environment for secure and resilient innovation.
